DK1645626T3 - Cellelinie - Google Patents
CellelinieInfo
- Publication number
- DK1645626T3 DK1645626T3 DK05255932T DK05255932T DK1645626T3 DK 1645626 T3 DK1645626 T3 DK 1645626T3 DK 05255932 T DK05255932 T DK 05255932T DK 05255932 T DK05255932 T DK 05255932T DK 1645626 T3 DK1645626 T3 DK 1645626T3
- Authority
- DK
- Denmark
- Prior art keywords
- cell line
- cell lines
- relates
- present
- accession nos
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
- C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0421753A GB0421753D0 (en) | 2004-09-30 | 2004-09-30 | Cell line |
GB0425767A GB0425767D0 (en) | 2004-11-23 | 2004-11-23 | Cell line |
GB0427830A GB0427830D0 (en) | 2004-12-20 | 2004-12-20 | Cell line |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1645626T3 true DK1645626T3 (da) | 2008-01-21 |
Family
ID=35744948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05255932T DK1645626T3 (da) | 2004-09-30 | 2005-09-23 | Cellelinie |
Country Status (9)
Country | Link |
---|---|
US (3) | US7416888B2 (da) |
EP (1) | EP1645626B1 (da) |
JP (1) | JP5036156B2 (da) |
AT (1) | ATE373081T1 (da) |
AU (1) | AU2005218041B2 (da) |
CA (1) | CA2521421C (da) |
DE (1) | DE602005002430T2 (da) |
DK (1) | DK1645626T3 (da) |
ES (1) | ES2294650T3 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9518606D0 (en) * | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
EP1645626B1 (en) * | 2004-09-30 | 2007-09-12 | Reneuron Limited | Cell line |
GB0822246D0 (en) | 2008-12-05 | 2009-01-14 | Reneuron Ltd | Composition |
GB0902034D0 (en) * | 2009-02-06 | 2009-03-11 | Reneuron Ltd | Method |
WO2011015573A1 (en) | 2009-08-03 | 2011-02-10 | Galapagos Nv | Molecular targets and compounds, and methods to identify the same, useful in the treatment of neurodegenerative diseases |
GB201011589D0 (en) * | 2010-07-09 | 2010-08-25 | Reneuron Ltd | Therapeutic cells |
GB201302468D0 (en) | 2013-02-12 | 2013-03-27 | Reneuron Ltd | Stem cell product |
AU2013245406B2 (en) * | 2012-04-03 | 2017-07-20 | Reneuron Limited | Stem cell microparticles |
CN104703609B (zh) | 2012-07-19 | 2019-02-19 | 兰诺龙有限公司 | 干细胞微粒 |
SG11201506284RA (en) | 2013-02-12 | 2015-09-29 | Reneuron Ltd | Method of producing microparticles |
GB201317887D0 (en) | 2013-10-09 | 2013-11-20 | Reneuron Ltd | Product |
GB201317889D0 (en) | 2013-10-09 | 2013-11-20 | Reneuron Ltd | Product and use |
US20200108100A1 (en) * | 2018-10-08 | 2020-04-09 | Reneuron Limited | Neural stem cell therapy for stroke |
US20210371828A1 (en) | 2018-10-12 | 2021-12-02 | Reneuron Limited | Induced pluripotent cell comprising a controllable transgene for conditional immortalization |
GB201911464D0 (en) | 2019-08-09 | 2019-09-25 | Reneuron Ltd | Genetic modification site |
GB201919021D0 (en) | 2019-12-20 | 2020-02-05 | Reneuron Ltd | Nucleic acid constructs for delivering polynucleotides into exosomes |
GB202005494D0 (en) | 2020-04-15 | 2020-05-27 | Reneuron Ltd | Induced pluripotent cell comprising a contollable transgene for conditional immortalisation |
GB202114441D0 (en) | 2021-10-08 | 2021-11-24 | Reneuron Ltd | Proteins and extracellular vesicles |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ226750A (en) | 1987-10-29 | 1990-09-26 | Amrad Corp Ltd | Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene |
DE68907220T2 (de) | 1988-04-12 | 1994-01-27 | Massachusetts Inst Technology | Verfahren zur manipulation des zelltyps von eukaryonten. |
US5270191A (en) | 1988-04-12 | 1993-12-14 | Massachusetts Institute Of Technology | Method for manipulation of the cell types of eukaryotes |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
WO1991009936A1 (en) | 1989-12-26 | 1991-07-11 | Hana Biologics, Inc. | Proliferated neuron progenitor cell product and process |
US5612211A (en) | 1990-06-08 | 1997-03-18 | New York University | Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors |
US5851832A (en) | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
WO1993001275A1 (en) | 1991-07-08 | 1993-01-21 | Neurospheres Ltd. | NOVEL GROWTH FACTOR-RESPONSIVE PROGENITOR CELLS WHICH CAN BE PROLIFERATED $i(IN VITRO) |
WO1993018137A1 (en) | 1992-03-04 | 1993-09-16 | Systemix, Inc. | Culturing of hematopoietic stem cells and their genetic engineering |
US5753491A (en) | 1993-04-13 | 1998-05-19 | Us Health | Use of neuro-derived fetal cell lines for transplantation therapy |
ES2170096T3 (es) | 1993-04-13 | 2002-08-01 | Us Gov Health & Human Serv | Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes. |
EP0792351B1 (en) | 1994-11-08 | 2004-03-10 | Cellfactors PLC | Method for producing a human neural cell line |
KR970707272A (ko) | 1994-11-14 | 1997-12-01 | 스코트 디. 코르맥 | 신경 간세포 증식 조절 방법(regulation of neural stem cell proliferation) |
US5843780A (en) | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
GB9517263D0 (en) | 1995-08-23 | 1995-10-25 | Cancer Res Campaign Tech | Expression systems |
GB9518606D0 (en) | 1995-09-12 | 1995-11-15 | Inst Of Psychiatry | Neural transplantation |
US5588692A (en) | 1995-10-11 | 1996-12-31 | General Motors Corporation | Push-out vehicle side door |
EP0773287A1 (en) * | 1995-11-07 | 1997-05-14 | Bayer Ag | Immortalised embryonic hyppocampal cells and their use |
US5770414A (en) * | 1996-02-20 | 1998-06-23 | The Regents Of The University Of California | Regulatable retrovirus system for genetic modification of cells |
US7544511B2 (en) * | 1996-09-25 | 2009-06-09 | Neuralstem Biopharmaceuticals Ltd. | Stable neural stem cell line methods |
AU740709B2 (en) | 1996-08-19 | 2001-11-15 | University Of Massachusetts | Embryonic or stem-like cell lines produced by cross species nuclear transplanta tion |
US20020123143A1 (en) | 1997-08-22 | 2002-09-05 | Jean Toma | Multipotent stem cells from peripheral tissues and uses thereof |
US5968829A (en) | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
JP2002513545A (ja) | 1998-05-07 | 2002-05-14 | ザ ユニヴァーシティー オブ サウス フロリダ | 脳および脊髄修復のためのニューロン源としての骨髄細胞 |
US5958767A (en) | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
GB9904281D0 (en) | 1999-02-24 | 1999-04-21 | Reneuron Ltd | Transplantation |
GB9907243D0 (en) | 1999-03-29 | 1999-05-26 | Reneuron Ltd | Therapy |
US6399384B1 (en) | 1999-09-17 | 2002-06-04 | Reneuron Limited | Conditional immortalization of cells |
US6465215B1 (en) | 1999-12-14 | 2002-10-15 | Reneuron Limited | Identification of cells for transplantation |
CA2393071A1 (en) * | 1999-12-07 | 2001-06-14 | Monash University | Long-term cell culture compositions and genetically modified animals derived therefrom |
EP1263930A4 (en) | 2000-03-09 | 2004-07-21 | Saneron Ccel Therapeutics Inc | BLOOD CELLS OF THE HUMAN UBILICAL CORD USED AS A SOURCE OF NEURAL TISSUE FOR REPAIRING THE BRAIN AND THE SPINAL CORD |
GB0005856D0 (en) * | 2000-03-10 | 2000-05-03 | Reneuron Ltd | Genetic constructs |
US7250294B2 (en) | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
US7049072B2 (en) | 2000-06-05 | 2006-05-23 | University Of South Florida | Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state |
AU2001264763A1 (en) | 2000-06-05 | 2001-12-17 | University Of South Florida | Human mesenchymal progenitor cell |
WO2003029432A2 (en) | 2001-10-03 | 2003-04-10 | University Of South Florida | Human mesenchymal progenitor cell |
GB0125773D0 (en) | 2001-10-26 | 2001-12-19 | Reneuron Ltd | Constructs |
US20040185429A1 (en) * | 2002-12-09 | 2004-09-23 | Judith Kelleher-Andersson | Method for discovering neurogenic agents |
EP1645626B1 (en) * | 2004-09-30 | 2007-09-12 | Reneuron Limited | Cell line |
-
2005
- 2005-09-23 EP EP05255932A patent/EP1645626B1/en active Active
- 2005-09-23 ES ES05255932T patent/ES2294650T3/es active Active
- 2005-09-23 DE DE602005002430T patent/DE602005002430T2/de active Active
- 2005-09-23 AT AT05255932T patent/ATE373081T1/de active
- 2005-09-23 DK DK05255932T patent/DK1645626T3/da active
- 2005-09-28 CA CA2521421A patent/CA2521421C/en active Active
- 2005-09-28 JP JP2005282179A patent/JP5036156B2/ja active Active
- 2005-09-29 US US11/238,702 patent/US7416888B2/en active Active
- 2005-09-30 AU AU2005218041A patent/AU2005218041B2/en not_active Ceased
- 2005-11-21 US US11/283,621 patent/US7419827B2/en active Active
-
2008
- 2008-01-28 US US12/020,874 patent/US7666672B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2521421A1 (en) | 2006-03-30 |
US7416888B2 (en) | 2008-08-26 |
AU2005218041B2 (en) | 2010-09-16 |
JP5036156B2 (ja) | 2012-09-26 |
AU2005218041A1 (en) | 2006-04-13 |
ES2294650T3 (es) | 2008-04-01 |
US20080118479A1 (en) | 2008-05-22 |
EP1645626A1 (en) | 2006-04-12 |
DE602005002430D1 (de) | 2007-10-25 |
ATE373081T1 (de) | 2007-09-15 |
JP2006122045A (ja) | 2006-05-18 |
EP1645626B1 (en) | 2007-09-12 |
US7666672B2 (en) | 2010-02-23 |
DE602005002430T2 (de) | 2008-06-19 |
US7419827B2 (en) | 2008-09-02 |
US20060104959A1 (en) | 2006-05-18 |
CA2521421C (en) | 2013-08-06 |
US20060067918A1 (en) | 2006-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE373081T1 (de) | Zelllinie | |
HK1173169A1 (en) | Dimercaptan terminated polythioether polymers and methods for making and using the same | |
RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
DK2308855T3 (da) | 2,4-Diaminopyrimidinderivater | |
DE602005010109D1 (de) | 1,1a,5,5a-tetrahydro-3-thia-cyclopropaäaüpentaleneptor-agonisten | |
ATE506362T1 (de) | 1-aza-bicycloä3.3.1ünonane | |
MX2010002028A (es) | Metodos y composiciones para modular celulas t. | |
AU304926S (en) | Paper trimmer | |
ITRM20020278A0 (it) | Verricello convertibile. | |
CA114740S (en) | Hair trimmer | |
ITBO20020698A1 (it) | Decespugliatore di tipo perfezionato. | |
ES1051317Y (es) | Mochila convertible. | |
Азімов et al. | Êîðîòê³ â³äîìîñò³ Êîðîòê³ â³äîìîñò³ ïðî àâòîð³â ïðî àâòîð³â | |
ITBA20040040A1 (it) | ELEFANTINO h.5,5 | |
PL114818U1 (en) | V .03 | |
ITLC20040002A1 (it) | P.p.0 | |
TW200500081A (en) | Novel rotaviruses and use thereof | |
UY34598A (es) | Antranilamidas insecticidas | |
ITRM20040039A1 (it) | Vaccino per l'ulcera. | |
HN2002000177A (es) | 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso. | |
BR8201431Y1 (pt) | disposiÇço construtiva aplicada em colhedeira. | |
ITBA20040055A1 (it) | Generatore n.g.2004 | |
HUP0301680A2 (hu) | Alul nyitott pontonok | |
ES1051120Y (es) | Mecanismo modificador del efecto sonoro en sordinas. | |
AU302041S (en) | Simple table |